Cargando…

Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases

OBJECTIVE: To investigate clinical reports of post-SSRI sexual dysfunction (PSSD), post-finasteride syndrome (PFS) and enduring sexual dysfunction following isotretinoin. METHODS: Data from RxISK.org, a global adverse event reporting website, have been used to establish the clinical features, demogr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Healy, David, Le Noury, Joanna, Mangin, Derelie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004900/ https://www.ncbi.nlm.nih.gov/pubmed/29733030 http://dx.doi.org/10.3233/JRS-180744

Ejemplares similares

Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
por: Healy, David, et al.
Publicado: (2022)

Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
por: Healy, David
Publicado: (2019)

The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
por: Traish, Abdulmaged M., et al.
Publicado: (2014)

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
por: Kiguradze, Tina, et al.
Publicado: (2017)

Antidepressants effect on sexual dysfunction in men with PTSD
por: Maalej, R., et al.
Publicado: (2021)

Antidepressants in bipolar depression: an enduring controversy
por: Gitlin, Michael J.
Publicado: (2018)

Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting
por: Lee, Kyoung-Uk, et al.
Publicado: (2010)

Antidepressant-associated sexual dysfunction: impact, effects, and treatment
por: Higgins, Agnes, et al.
Publicado: (2010)

Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
por: Zhang, Jun-Jie, et al.
Publicado: (2021)

Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: Clinical description and the role of the 5-HTTLPR
por: Strohmaier, Jana, et al.
Publicado: (2011)

Metabolic dysfunction in female mice with disruption of 5α-reductase 1
por: Livingstone, Dawn E W, et al.
Publicado: (2016)

5α-reductase inhibitors impact prognosis of urothelial carcinoma
por: Wang, Chien-Sheng, et al.
Publicado: (2020)

Is There a Link between 5α-Reductase Inhibitors and Hypoglycemia?
por: Jeong, Jin Woo, et al.
Publicado: (2021)

Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
por: Garcia-Argibay, Miguel, et al.
Publicado: (2022)

Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study
por: Clarke, Caroline S., et al.
Publicado: (2021)

Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach
por: Montejo, Angel L., et al.
Publicado: (2019)

Correction to: Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study
por: Clarke, Caroline S., et al.
Publicado: (2021)

Current Status of 5α-Reductase Inhibitors in Prostate Disease Management
por: Kang, Dong Il, et al.
Publicado: (2013)

Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib
por: Caruana, Marco, et al.
Publicado: (2020)

Prevalence and pattern of sexual dysfunction in married females receiving antidepressants: An exploratory study
por: Grover, Sandeep, et al.
Publicado: (2012)

Cardiovascular Outcomes of α-Blockers vs 5-α Reductase Inhibitors for Benign Prostatic Hyperplasia
por: Zhang, Jiandong, et al.
Publicado: (2023)

Isotretinoin and psychopathology: a review
por: Kontaxakis, Vassilis P, et al.
Publicado: (2009)

Acute psychosis induced by isotretinoin
por: Rajagopal, Sundararajan
Publicado: (2014)

Isotretinoin-induced skeletal hyperostosis
por: Graf, Scott W, et al.
Publicado: (2014)

Isotretinoin-Induced Night Blindness
por: Madke, Bhushan, et al.
Publicado: (2015)

Isotretinoin and the Kidney: Opportunities and Threats
por: Forouzani-Haghighi, Bahareh, et al.
Publicado: (2020)

Acute Pancreatitis Caused by Isotretinoin
por: Ashraf, Muddasir
Publicado: (2020)

Use of 5α-reductase inhibitor and delay in prostate cancer diagnosis and treatment
por: Busato, Wilson F. S.
Publicado: (2020)

Antidepressants and sexual adverse effects
Publicado: (2021)

Reduced Treatment-Emergent Sexual Dysfunction as a Potential Target in the Development of New Antidepressants
por: Baldwin, David S., et al.
Publicado: (2013)

Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
por: Ben-Sheetrit, Joseph, et al.
Publicado: (2023)

Computer aided screening of inhibitors to 5-α reductase type 2 for prostate cancer
por: Bhattacharjee, Biplab, et al.
Publicado: (2011)

5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
por: Robinson, David, et al.
Publicado: (2015)

Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
por: Tampucci, Silvia, et al.
Publicado: (2022)

Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
por: Poirier, Andrée-Anne, et al.
Publicado: (2022)

Angiolymphoid hyperplasia with eosinophilia: efficacy of isotretinoin?
por: El Sayed, Fouad, et al.
Publicado: (2006)

Hypoacusia in a Patient Treated by Isotretinoin
por: Rosende, L., et al.
Publicado: (2011)

Exacerbation of inflammatory bowel disease with isotretinoin
por: Bharmal, Rabaab, et al.
Publicado: (2010)

Isotretinoin Exposure and Risk of Celiac Disease
por: Rashtak, Shadi, et al.
Publicado: (2015)

Angioedema due to Systemic Isotretinoin Therapy
por: Üstüner, Pelin
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_di0vfang89sn28n2pmvn57t1mp